Skip to content ↓

Topic

Computer Science and Artificial Intelligence Laboratory (CSAIL)

Download RSS feed: News Articles / In the Media / Audio

Displaying 196 - 210 of 759 news clips related to this topic.
Show:

The Boston Globe

Prof. Ronitt Rubinfeld has been named a John Simon Guggenheim Foundation fellow, reports Mark Feeney for The Boston Globe. “A ‘Guggenheim’ is one of the most sought-after honors in academe and culture,” explains Feeney. “It helps underwrite a proposed art or scholarly project.”  

WBUR

Prof. Marzyeh Ghassemi speaks with WBUR reporter Geoff Brumfiel about her research studying the use of artificial intelligence in healthcare. “When you take state-of-the-art machine learning methods and systems and then evaluate them on different patient groups, they do not perform equally,” says Ghassemi.

WHDH 7

Researchers at MIT have created a four-legged robot called DribbleBot, reports Caroline Goggin for WHDH. The robot “can dribble a soccer ball under the same conditions as humans, using onboard sensors to travel across different types of terrain.”

Popular Science

Popular Science reporter Andrew Paul spotlights how researchers from MIT CSAIL have developed a soccer-playing robot, dubbed DribbleBot, that can handle a variety of real-world terrains. “DribbleBot showcases extremely impressive strides in articulation and real-time environmental analysis. Using a combination of onboarding computing and sensing, the team’s four-legged athlete can reportedly handle gravel, grass, sand, snow, and pavement, as well as pick itself up if it falls.”

TechCrunch

MIT researchers have created “Dribblebot,” a four-legged robot capable of playing soccer across varying terrain, reports Brian Heater for TechCrunch.

Boston.com

Researchers at MIT have created a four-legged robot capable of dribbling a soccer ball and running across a variety of terrains, reports Ross Cristantiello for Boston.com. “Researchers hope that they will be able to teach the robot how to lift a ball over a step in the future,” writes Cristantiello. “They will also explore how the technology behind DribbleBot can be applied to other robots, allowing machines to quickly transport a range of objects around outside using legs and arms.”

Scientific American

Prof. Marzyeh Ghassemi speaks with Scientific American reporter Sara Reardon about the impact of AI chatbots on medical care. “Ghassemi is particularly concerned that chatbots will perpetuate the racism, sexism and other types of prejudice that persist in medicine—and across the Internet,” writes Reardon. “Scrubbing racism from the Internet is impossible, but Ghassemi says developers may be able to do preemptive audits to see where a chatbot gives biased answers and tell it to stop or to identify common biases that pop up in its conversations with users.”

TechCrunch

Venti Technologies, a startup co-founded by MIT professors and alumni that builds autonomous vehicles for industrial and logistics centers, has raised $29 million in Series A funding. The company’s “target customer comes from the wide range of supply chain businesses that operate across warehouses, ports and other shipping and logistics environments where vehicles — currently driven by humans — are central to operations,” writes Ingrid Lunden for TechCrunch.

Forbes

Bob Metcalfe ’69, a CSAIL research affiliate and MIT Corporation life member emeritus, has been awarded this year’s Turing Award for his work inventing Ethernet, reports Randy Bean for Forbes. “Turing recipients include the greatest pioneers in the advancement of computer science,” says Metcalfe. “I am grateful to be considered among these giants.”

Financial Times

Researchers at MIT have quantified the shift toward the artificial intelligence industry and how it has impacted academia, reports Madhumita Murgia for Financial Times. “The MIT research found that almost 70 percent of AI PhDs went to work for companies in 2020, compared to 21 per cent in 2004,” writes Murgia.

The New York Times

This year's Turing Award has been awarded to Bob Metcalfe ’69, a CSAIL research affiliate and MIT Corporation life member emeritus, for his work inventing Ethernet, a computer networking technology that for decades “has connected PCs to servers, printers and the internet in corporate offices and homes across the globe,” writes Cade Metz for The New York Times. “Almost everything you do online goes through Ethernet at some stage,” said Marc Weber of the Computer History Museum.

Reuters

Bob Metcalfe ’69, a CSAIL research affiliate and MIT Corporation life member emeritus, has been honored as this year’s recipient of the Turing Award for the invention of the Ethernet, “a technology that half a century after its creation remains the foundation of the internet,” reports Stephen Nellis for Reuters. “The Ethernet got its start when Metcalfe, who later went on to co-found computing network equipment maker 3Com, was asked to hook up the office printer,” writes Nellis.

The Boston Globe

CSAIL research affiliate and MIT Corporation life member emeritus Bob Metacalfe ‘69 has been awarded the 2022 Turing Award for his contributions to creating Ethernet, a method for enabling personal computers to communicate directly with one another over a wired connection, reports Hiawatha Bray for The Boston Globe. “Variants of the original Ethernet connect countless millions of computers around the world,” writes Bray.

Boston.com

Using an artificial intelligence system, researchers at MIT and elsewhere have developed a new Covid-19 vaccine that could be effective against current and future strains, reports Gwen Egan for Boston.com. “The vaccine differs from others currently on the market due to the portion of the virus being targeted,” writes Egan.  

The Boston Globe

Boston Globe reporter Hiawatha Bray writes that MIT researchers have used an AI system to identify a potential new Covid-19 vaccine that may be effective against both current and future variants of the virus. “The new vaccine targets a portion of the COVID virus that is much less prone to evolve,” writes Bray. “That could potentially make it effective against many different versions of the virus, eliminating the need for routine booster shots.”